SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-K - Annual report [Section 13 and 15(d), not S-K Item 405]:
SEC Accession No. 0001513162-19-000016
Filing Date
2019-01-11
Accepted
2019-01-11 16:31:23
Documents
62
Period of Report
2018-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 10-K form10k.htm 10-K 1572443
2 EXHIBIT 21 exhibit21.htm EX-21 14984
3 EXHIBIT 23.1 exhibit23_1.htm EX-23.1 1856
4 EXHIBIT 31.1 exhibit31_1.htm EX-31.1 10531
5 EXHIBIT 31.2 exhibit31_2.htm EX-31.2 10688
6 EXHIBIT 32.1 exhibit32_1.htm EX-32.1 9122
7 EXHIBIT 32.2 exhibit32_2.htm EX-32.2 9843
  Complete submission text file 0001513162-19-000016.txt   5765744

Data Files

Seq Description Document Type Size
8 XBRL INSTANCE DOCUMENT anix-20181031.xml EX-101.INS 1048196
9 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT anix-20181031.xsd EX-101.SCH 49471
10 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT anix-20181031_cal.xml EX-101.CAL 37275
11 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT anix-20181031_def.xml EX-101.DEF 294261
12 XBRL TAXONOMY EXTENSION LABELS LINKBASE DOCUMENT anix-20181031_lab.xml EX-101.LAB 369075
13 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT anix-20181031_pre.xml EX-101.PRE 292693
Mailing Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118
Business Address 3150 ALMADEN EXPRESSWAY, SUITE 250 SAN JOSE CA 95118 408-708-9808
Anixa Biosciences Inc (Filer) CIK: 0000715446 (see all company filings)

IRS No.: 112622630 | State of Incorp.: DE | Fiscal Year End: 1031
Type: 10-K | Act: 34 | File No.: 001-37492 | Film No.: 19522594
SIC: 8071 Services-Medical Laboratories
Assistant Director 9